2009
DOI: 10.1371/journal.pone.0008014
|View full text |Cite
|
Sign up to set email alerts
|

Protective Role of R-spondin1, an Intestinal Stem Cell Growth Factor, against Radiation-Induced Gastrointestinal Syndrome in Mice

Abstract: BackgroundRadiation-induced gastrointestinal syndrome (RIGS) results from a combination of direct cytocidal effects on intestinal crypt and endothelial cells and subsequent loss of the mucosal barrier, resulting in electrolyte imbalance, diarrhea, weight loss, infection and mortality. Because R-spondin1 (Rspo1) acts as a mitogenic factor for intestinal stem cells, we hypothesized that systemic administration of Rspo1 would amplify the intestinal crypt cells and accelerate the regeneration of the irradiated int… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

9
89
0
2

Year Published

2010
2010
2023
2023

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 108 publications
(100 citation statements)
references
References 41 publications
9
89
0
2
Order By: Relevance
“…Natural Wnt agonists, such as members of the R-spondin family, have recently been shown to protect intestinal stem cells in mice after radiation-induced intestinal damage. More specifically it reduces epithelial cell death and improves functional regeneration of the intestinal tract [11]. This highlights the great promises held by natural and chemical compounds activating the Wnt pathway in regenerative medicine.…”
mentioning
confidence: 85%
“…Natural Wnt agonists, such as members of the R-spondin family, have recently been shown to protect intestinal stem cells in mice after radiation-induced intestinal damage. More specifically it reduces epithelial cell death and improves functional regeneration of the intestinal tract [11]. This highlights the great promises held by natural and chemical compounds activating the Wnt pathway in regenerative medicine.…”
mentioning
confidence: 85%
“…These interventions seek to increase radiation tolerance, ameliorate secondary normal tissue injury, or enhance repair capacity. Such approaches include, for example, various immunemodulating drugs 74,75 , enterotrophic agents [76][77][78][79][80][81][82][83] , compounds that modulate intraluminal contents 84,85 , and a variety of other strategies [86][87][88][89][90][91] . Interventions that target downstream radiation effects may be generally more appealing in the cancer treatment situation because they do not interfere directly with the mechanism of radiation.…”
Section: Preclinical Research To Prevent Radiation Enteropathymentioning
confidence: 99%
“…Subsequently, the intestinal epithelial stem cells begin to differentiate, proliferate, and repair the damaged intestinal mucosa (Gang, 2009). Rspo1 itself may protect mice from experimental colitis or from chemotherapy or radiotherapy-induced mucosal injury (Zhao et al, 2007(Zhao et al, , 2009Bhanja et al, 2009) and is necessary for normal ductal development in breasts (Chadi et al, 2009). Additionally, Rspo1 plays a key role during vertebrate development (Kim et al, 2005) and an effective mitogenic factor of gastrointestinal epithelial cells.…”
Section: Introductionmentioning
confidence: 99%